Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007342 |
---|---|
Receipt number | R000008655 |
Scientific Title | Phase II study of tri-weekly administration of nanoparticle albumin-bound-paclitaxel for first-line chemotherapy in advanced and metastatic HER2- negative breast cancer |
Date of disclosure of the study information | 2012/02/27 |
Last modified on | 2014/02/24 19:07:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/02/21 13:19:54 | ||
2 | Update | 2012/07/04 14:24:41 | Last follow-up date |
|
3 | Update | 2012/08/21 10:14:11 | Last follow-up date |
|
4 | Update | 2013/02/21 14:27:24 | Key inclusion criteria |
|
5 | Update | 2014/02/24 19:07:03 | Recruitment status |